Shareholders Equity: The sum of preferred and common equity items.
Medicenna Therapeutics Corp. (T.MDN) had Shareholders Equity of 13.72M for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-8.48M |
|
-- |
|
-- |
|
-- |
|
-14.66M |
|
-- |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-8.48M |
|
-14.66M |
|
-14.62M |
|
76.67M |
|
76.67M |
|
-0.11 |
|
-0.11 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
20.39M |
|
-- |
|
-- |
|
-- |
|
6.67M |
|
13.72M |
|
13.68M |
|
|
Shareholders Equity |
13.72M |
78.22M |
|
| Cash Flow Statement Financials | |
-11.85M |
|
-0.02M |
|
16.88M |
|
12.20M |
|
17.84M |
|
5.64M |
|
1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.35 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-61.82% |
|
-61.99% |
|
-41.59% |
|
-61.44% |
|
0.24 |
|
-0.15 |
|
-0.15 |
|